Recent Developments of Protein Kinase Inhibitors as Potential AD Therapeutics
Present AD therapies suffer from inefficient effects on AD symptoms like memory or cognition, especially in later states of the disease. Used acteylcholine esterase (ACE) inhibitors or the NMDA receptor antagonist memantine address one target structure which is involved in a complex, multifactorial...
Main Authors: | Andreas eHilgeroth, Volkmar eTell |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-11-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fncel.2013.00189/full |
Similar Items
-
Aurora kinase inhibitors: current status and outlook
by: Vassilios eBavetsias, et al.
Published: (2015-12-01) -
Influenza Virus Infections and Cellular Kinases
by: Robert Meineke, et al.
Published: (2019-02-01) -
The Azaindole Framework in the Design of Kinase Inhibitors
by: Jean-Yves Mérour, et al.
Published: (2014-11-01) -
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
by: Mohammad Hojjat-Farsangi
Published: (2014-08-01) -
Small-Molecule Inhibitor Targeting Protein Kinase D: A Potential Therapeutic Strategy
by: Die Lv, et al.
Published: (2021-06-01)